Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
about
On the role of classical and novel forms of vitamin D in melanoma progression and management.MEK inhibitors cobimetinib and trametinib, regressed a gemcitabine-resistant pancreatic-cancer patient-derived orthotopic xenograft (PDOX)Toxicology and efficacy of tumor-targeting Salmonella typhimurium A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice.Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma.A novel anionic-phosphate-platinum complex effectively targets an undifferentiated pleomorphic sarcoma better than cisplatinum and doxorubicin in a patient-derived orthotopic xenograft (PDOX)Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide.Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with a FUS-ERG fusion and CDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model.Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and Metastasis in a Syngeneic Pancreatic-Cancer Orthotopic Mouse Model.Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model.Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.Growth of doxorubicin-resistant undifferentiated spindle-cell sarcoma PDOX is arrested by metabolic targeting with recombinant methioninase.The combination of temozolomide-irinotecan regresses a doxorubicin-resistant patient-derived orthotopic xenograft (PDOX) nude-mouse model of recurrent Ewing's sarcoma with a FUS-ERG fusion and CDKN2A deletion: Direction for third-line patient therapIndividualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patients.Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: Decoy, trap and kill chRegorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 in a patient-derived orthotopic xenograft (PDOX) nude mouse model.Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models.CKS1 expression in melanocytic nevi and melanoma.Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella.Genetic and metabolic comparison of orthotopic and heterotopic patient-derived pancreatic-cancer xenografts to the original patient tumors.Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models.Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.Cancer Immunotherapy: Priming the Host Immune Response with Live AttenuatedTrabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
P2860
Q38662850-EF0C5B7D-FB02-42B4-A7F1-1BA2E2A37632Q41471129-8DC43400-DD17-49C9-9919-21BE7D2879E1Q41551244-85738B1D-B056-4173-B918-C706150EE8CEQ41661119-D498E81A-5C34-4A68-8E1E-0639698250F3Q42362667-8CC86BB4-D6E1-4BF0-9A43-04803E772731Q46020823-04966971-DD4E-46D4-A2FB-ADFD4539AB42Q46023921-D6F50EA4-20F2-44C9-A2AC-0AA89299710FQ46115870-22396BE3-F2BD-4CE4-AF02-FE73BB7885E7Q46198099-8389E5F6-3522-4458-A104-1281A1D0C12EQ46341637-81F99A21-9FB5-494C-9F4C-3AC3E56B4E91Q46417828-5E6620DE-F949-40E7-9209-A1B8465EFA58Q47105755-DF8DD76E-0D64-40C6-B421-7A457EA516F6Q48135854-92FBEF26-6847-4EDE-9189-2AA5C2A85F41Q48156221-4724F66C-063C-4C85-8EA7-6F8A3C4FEC23Q48243511-1CACB017-A001-4AB0-8FB0-24251AF57D9DQ49185022-AE1959AF-8EC3-48C1-A954-1AF111CF8BA3Q49738986-C1110250-CDB3-4B48-8DED-5B3557F291B9Q50317370-8B2CB19D-3476-4FCF-92AE-8C932F149530Q50353132-1D11C020-8A58-41D9-AB25-37EF652F7877Q52603159-CF8003D2-D611-4541-9669-08933901AA61Q52655050-CB01E9F1-938A-44D0-A2B4-9E8C01CEC541Q55076815-6395B7EF-A259-4E63-895F-1B7DC0BD3765Q57300412-A4A081C3-F278-49CF-9ECE-BA8AA58AD4CEQ58736789-7439B78C-CEAC-42D5-854C-FF55C13815B4
P2860
Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Tumor-Targeting Salmonella typ ...... graft (PDOX) Nude Mouse Model.
@en
Tumor-Targeting Salmonella typ ...... t-Derived Orthotopic Xenograft
@nl
type
label
Tumor-Targeting Salmonella typ ...... graft (PDOX) Nude Mouse Model.
@en
Tumor-Targeting Salmonella typ ...... t-Derived Orthotopic Xenograft
@nl
prefLabel
Tumor-Targeting Salmonella typ ...... graft (PDOX) Nude Mouse Model.
@en
Tumor-Targeting Salmonella typ ...... t-Derived Orthotopic Xenograft
@nl
P2093
P2860
P356
P1476
Tumor-Targeting Salmonella typ ...... graft (PDOX) Nude Mouse Model.
@en
P2093
Bartosz Chmielowski
Fritz C Eilber
Kei Kawaguchi
Michiaki Unno
Robert M Hoffman
Sarah M Dry
Scott D Nelson
Tara A Russell
Tasuku Kiyuna
P2860
P304
P356
10.1002/JCB.25886
P577
2017-01-20T00:00:00Z